Evidence map›Paper›PMID 28680998›Full record

ArticleCurrent medical mycology2015

M Abastabar, T Shokohi, R Rouhi Kord, H Badali, S J Hashemi, Z Ghasemi, A Ghojoghi, N Baghi, M Abdollahi, S Hosseinpoor and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Current medical mycology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Antifungal Resistance of ClinicalIranian journal of public health · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

M AbastabarInvasive Fungi Research Center (IFRC), Department of Medical Mycology and Parasitology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
T ShokohiInvasive Fungi Research Center (IFRC), Department of Medical Mycology and Parasitology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
R Rouhi KordStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
H BadaliInvasive Fungi Research Center (IFRC), Department of Medical Mycology and Parasitology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
S J HashemiDepartment of Medical Parasitology and Mycology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Z GhasemiDepartment of Medical Parasitology and Mycology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
A GhojoghiToxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
N BaghiStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
M AbdollahiStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
S HosseinpoorStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
N RahimiStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
Z SeifiStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
S GholamiInvasive Fungi Research Center (IFRC), Department of Medical Mycology and Parasitology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
I HaghaniInvasive Fungi Research Center (IFRC), Department of Medical Mycology and Parasitology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
M R JabariStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
A PaghehStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
Mazandaran University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeMATERIALS AND

methods

resultsThe MIC of econazole, itraconazole, miconazole, and fluconazole were within the range of 0.016-16, 0.032-16, 0.016-16, and 0.25-64 μg/ml, respectively. In general, econazole and miconazole were more active against

conclusionThe present study demonstrated that for

Indexed as

AntifungalCandidiasisEconazole

Identifiers

PMID28680998
PMCPMC5490275
OpenAlexW2551422950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.